BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2652626)

  • 1. Analysis of spontaneous blastogenesis profiles in recipients of renal allografts.
    Yoon YS; Cheigh JS; Riggio RR; Stenzel KH; Suthanthiran M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1925. PubMed ID: 2652626
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroids and leukocyte blastogenesis in renal transplantation.
    Pierce GE; Thomas JH; Vessella RL; Hermreck AS; Barth RF
    Transplant Proc; 1979 Mar; 11(1):364-9. PubMed ID: 377657
    [No Abstract]   [Full Text] [Related]  

  • 3. [Spontaneous proliferative response in patients with chronic renal allograft insufficiency due to chronic rejection].
    Savin M; Ramić Z; Mostarica-StojkovićM ; Djukanović Lj
    Srp Arh Celok Lek; 1994; 122(5-6):142-5. PubMed ID: 17977411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of peripheral blood lymphocytes to recombinant interleukin-2 in kidney transplant recipients.
    Koda N; Oda T; Yokoyama M; Matsumoto A; Takeuchi M
    Transplant Proc; 1990 Oct; 22(5):2373-5. PubMed ID: 2219405
    [No Abstract]   [Full Text] [Related]  

  • 5. Gramicidin as a potential immunosuppressant for organ transplantation: suppression of human lymphocyte blastogenesis in vitro and prolongation of heart allograft survival in the rat.
    Hirano T; Oka K; Tamaki T
    J Pharmacol Exp Ther; 1995 Apr; 273(1):223-9. PubMed ID: 7536243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of renal allograft rejection by direct lymphocyte blastogenesis assay.
    Uehling D; Segal M; Hussey J; Kan CM; Bach F
    Invest Urol; 1977 May; 14(6):431-3. PubMed ID: 323185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composition, subclass distribution, and preliminary analysis of the functions of host inflammatory cells infiltrating renal allografts during rejection.
    Häyry P; Soots A; von Willebrand E; Wiktorowicz K
    Transplant Proc; 1979 Mar; 11(1):785-9. PubMed ID: 377712
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue typing by unidirectional mixed lymphocyte culture. 3. The relationship of in vitro lymphocyte compatibility to renal allograft rejection.
    Tsunemitsu K
    Acta Med Okayama (1952); 1971; 25(1):65-9. PubMed ID: 4258666
    [No Abstract]   [Full Text] [Related]  

  • 10. In situ analysis of cells involved in irreversible acute rejection of human renal allografts.
    Charpentier B; Bach MA; Lang P; Hiesse C; Fries D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):392-3. PubMed ID: 3274791
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential effects of immunosuppressive agents on human lymphocyte subpopulations: suppressive agent and individual recipient variables.
    Thomas FT; Thomas JM; Lower RR; Mendez G; Lee HM
    Surg Forum; 1977; 28():325-7. PubMed ID: 364725
    [No Abstract]   [Full Text] [Related]  

  • 12. FK506 inhibits human lymphocyte migration and the production of lymphocyte chemotactic factors in liver allograft recipients.
    Adams DH; Liu Q
    Hepatology; 1996 Jun; 23(6):1476-83. PubMed ID: 8675167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous blastogenesis as a monitor of renal allograft rejection.
    Kanda H; Kunikata S; Matsuura T; Akiyama T; Kurita T
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1592-4. PubMed ID: 3547869
    [No Abstract]   [Full Text] [Related]  

  • 14. CsA therapy affects the direct and indirect antigen-presentation pathway in cardiac allograft recipients.
    van Besouw NM; Vaessen LM; Balk AH; Mochtar B; Claas FH; Weimar W
    Transplant Proc; 1996 Dec; 28(6):3135-6. PubMed ID: 8962214
    [No Abstract]   [Full Text] [Related]  

  • 15. Cimetidine modulation of lymphocytes from renal allograft recipients.
    Gifford RR; Schmidtke JR; Ferguson RM
    Transplant Proc; 1981 Mar; 13(1 Pt 1):663-7. PubMed ID: 6455809
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive effect of stepronin (TS-5010680) in mice.
    de Giorgi L; Arrigoni-Martelli E; Matossian-Rogers A
    Transplant Proc; 1994 Dec; 26(6):3513-6. PubMed ID: 7998255
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effect of immunosuppressive agents on T and B lymphocytes.
    Thomas F; Owens L; Thomas J; Wolf JS; Volk M; Mendez G; Lee HM
    Proc Clin Dial Transplant Forum; 1974; (4):124-9. PubMed ID: 4619655
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous blastogenesis and protein synthesis as monitors of renal allograft rejection.
    Thomas JH; Kinnaman ML; Pierce GE; Shaw LW; Clancy J
    Transplant Proc; 1984 Dec; 16(6):1600-2. PubMed ID: 6390871
    [No Abstract]   [Full Text] [Related]  

  • 19. Pretransplant blood transfusions and kidney allograft survival. A clinical and immunological study.
    Fehrman I
    Scand J Urol Nephrol Suppl; 1981; 65():1-46. PubMed ID: 6217543
    [No Abstract]   [Full Text] [Related]  

  • 20. An immune monitoring program for controlling immunosuppressive therapy.
    Baehr RV; Volk HD; Reinke P; Falck P; Wolff H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1189-91. PubMed ID: 2495594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.